Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Arcutis Biotherapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- +8 vs. Q1 2021
- Shares held
- 45.5M
- −1.37M (−2.9%) vs. Q1 2021
- Total value
- $1.24B
- −$114.1M (−8.4%) vs. Q1 2021
- New holders
- 23
- 40 more added
- Sold out
- 15
- 25 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 7,530,740 | $205.5M | 0.02% | −105,709−1.4% | Reduced |
| Frazier Management LLC | 8,434,232 | $230.2M | 21.23% | −2,108,558−20.0% | Reduced |
| Maven Securities LTD | 0 | $0 | 0.00% | −116,728−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −96,954−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −36,700−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −15,093−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,649−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −8,010−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −7,208−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −7,152−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −6,979−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −887−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −677−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −282−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |